ABSTRACT

As improved antithrombotic strategies continue to reduce the incidence of ischemic events, bleeding is gaining recognition as the most common complication in patients undergoing percutaneous coronary intervention (PCI) for stable coronary artery disease (CAD) or acute coronary syndromes (ACS). Because hemorrhagic events confer an unfavorable prognosis in patients treated with PCI, bleeding complications and ways of preventing them assume particular importance.